Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 24, 2010

Premium

Oligonucleotide manufacturer Girindus has named Edward Huber as its director of analytical development and quality control.

Huber previously held a variety of positions at Marion Merrell Dow, Hoechst Marion Roussel, Aventis, and Patheon. He has a PhD in analytical chemistry from the University of Cincinnati.


Agios Pharmaceuticals has appointed Alnylam Pharmaceuticals CEO John Maraganore to its board of directors.

Maraganore is the first independent director of Agios, which is developing drugs in the area of cancer metabolism.

Prior to Alnylam, Maraganore was an officer and a member of the management team for Millennium Pharmaceuticals, where he was oversaw the company's efforts in oncology, cardiovascular, inflammation, and metabolic diseases. Before Millennium, he worked in molecular biology and business development at Biogen, ZymoGenetics, and the Upjohn Company.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.